Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

NCT00597441 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.

NCT NCT00597441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00597441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation
Lead sponsor
Sumitomo Pharma Switzerland GmbH
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2005
Completion date
May 31, 2010
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stem cell transplantation